Skip to main content
. 2015 Jun 17;10(6):e0129072. doi: 10.1371/journal.pone.0129072

Fig 3. Identification of functional CreERT2-driver lines.

Fig 3

(A) Scheme of the embryonic functionality assay. (B) 27 CreERT2-driver lines are shown with respect to CreERT2 expression at 24 hpf (CreERT2) and the respective embryonic functionality assay indicated by native EGFP fluorescence.